The Behavioral Sciences Core (BSC) was added with the 2005 renewal application. The BSC was developed following a needs analysis by the CFAR and in response to member surveys in 2003 and 2004. It is based on strong capabilities of The University of Texas Health Science Center at Houston (UTHouston) in applying behavioral sciences to HIV/AIDS research, complemented by the strong clinical and basic sciences that exist at Baylor College of Medicine and UTHouston. The Core is led by Dr. R.M. Grimes and is housed at The University of Texas Health Science Center at Houston. The objectives of the Core are: (1) To facilitate behavioral science research in HIV/AIDS prevention and care, and (2) To integrate behavioral sciences into clinical and basic HIV/AIDS research studies. These objectives are accomplished by providing expertise in services utilized by behavioral scientists and by making these readily available to clinicians and basic researchers who want to include a behavioral component to their studies. Core services include providing expertise in study design, facilitating questionnaire development, and the design and interpretation of qualitative studies. The Core has been highly successful in encouraging HIV/AIDS research that includes a behavioral component. The Core also places a high priority on its support of interdisciplinary studies proposed by CFAR leadership that target research in areas that represent gaps at our CFAR and that encourage new interactions among CFAR cores and CFAR members at Baylor and UTHouston.
The Center for AIDS Research (CFAR) at Baylor-UTHouston supports research on the pathogenesis, prevention, detection, and treatment of HIV infection and AIDS. The CFAR has been an essential catalyst for HIV/AIDS research in the Houston area. The State of Texas ranks fourth in the total number of AIDS cases in the United States. The Behavioral Sciences Core provides help in designing questionnaires and in the interpretation of studies of behavior associated with HIV and AIDS.
|Lam, Sharon; Sung, Julia; Cruz, Conrad et al. (2015) Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy. Mol Ther 23:387-95|
|Gordon, Alasdair J E; Satory, Dominik; Wang, Mengyu et al. (2014) Removal of 8-oxo-GTP by MutT hydrolase is not a major contributor to transcriptional fidelity. Nucleic Acids Res 42:12015-26|
|Cerne, Jasmina Ziva; Hartig, Sean Michael; Hamilton, Mark Patrick et al. (2014) Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation. Invest Ophthalmol Vis Sci 55:2130-9|
|Blackmore, Julia K; Karmakar, Sudipan; Gu, Guowei et al. (2014) The SMRT coregulator enhances growth of estrogen receptor-?-positive breast cancer cells by promotion of cell cycle progression and inhibition of apoptosis. Endocrinology 155:3251-61|
|Singh, Ravi K; Xia, Zheng; Bland, Christopher S et al. (2014) Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol Cell 55:592-603|
|Fongkaew, Warunee; Viseskul, Nongkran; Suksatit, Benjamas et al. (2014) Verifying quantitative stigma and medication adherence scales using qualitative methods among Thai youth living with HIV/AIDS. J Int Assoc Provid AIDS Care 13:69-77|
|Nguyen, Dan; Hsu, Jean W; Jahoor, Farook et al. (2014) Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients. J Clin Endocrinol Metab 99:169-77|
|Chen, Jiyuan; Xia, Yunfeng; Lin, Xia et al. (2014) Smad3 signaling activates bone marrow-derived fibroblasts in renal fibrosis. Lab Invest 94:545-56|
|Ross, Michael W; Nyoni, Joyce; Ahaneku, Hycienth O et al. (2014) High HIV seroprevalence, rectal STIs and risky sexual behaviour in men who have sex with men in Dar es Salaam and Tanga, Tanzania. BMJ Open 4:e006175|
|Santiago, Felix W; Covaleda, Lina M; Sanchez-Aparicio, Maria T et al. (2014) Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol 88:4572-85|
Showing the most recent 10 out of 248 publications